Next generation antidepressants with novel mechanisms for treatment resistant depression

Keyphrases

• Novel Mechanism 100%
• Antidepressants 100%
• Treatment-resistant Depression 100%
• Neuroplasticity 66%
• Ketamine 66%
• Psilocybin 66%
• N-methyl-D-aspartate Receptor (NMDAR) 33%
• United States Food 33%
• States of Consciousness 33%
• Major Depressive Disorder 33%
• Suicidal Ideation 33%
• Rapid-acting Antidepressant 33%
• 5-hydroxytryptamine Receptors 33%
• Phase II Clinical Trial 33%
• Neuromechanism 33%
• Psychedelics 33%

Neuroscience

• Antidepressant 100%
• Treatment-Resistant Depression 100%
• Neuroplasticity 66%
• Psilocybin 66%
• Aspartic Acid 33%
• Major Depressive Disorder 33%
• Ketamine 33%
• 5-HT Receptor 33%
• Psychotomimetic 33%
• Esketamine 33%
• Receptor 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Antidepressant 100%
• Treatment Resistant Depression 100%
• Psilocybin 66%
• Clinical Trial 33%
• Receptor 33%
• Major Depression 33%
• Aspartic Acid 33%
• Ketamine 33%
• Psychotomimetic 33%
• Serotonin Receptor 33%
• Esketamine 33%